ProfileGDS4718 / 219973_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 18% 23% 45% 28% 40% 30% 21% 20% 30% 25% 29% 34% 62% 28% 73% 85% 51% 52% 57% 30% 27% 45% 37% 20% 60% 32% 30% 16% 14% 25% 77% 40% 18% 24% 20% 26% 30% 26% 21% 57% 21% 31% 66% 22% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0972618
GSM549102patient 115, normal, homogenized [OPG study]4.263323
GSM549104patient 119, normal, homogenized [OPG study]5.2091245
GSM549108patient 138, normal, homogenized [OPG study]4.5117628
GSM549119patient 077, normal, homogenized [OPG study]4.9865340
GSM549133patient 032, cancer, homogenized [OPG study]4.4909230
GSM549139patient 042, cancer, homogenized [OPG study]4.1579721
GSM549099patient 107, normal, homogenized [OPG study]4.1709320
GSM549109patient 139, normal, homogenized [OPG study]4.5492330
GSM549110patient 046, normal, homogenized [OPG study]4.3336725
GSM549114patient 063, normal, homogenized [OPG study]4.4682529
GSM549122patient 082, normal, homogenized [OPG study]4.7090434
GSM549134patient 033, cancer, homogenized [OPG study]6.2246562
GSM549136patient 036, cancer, homogenized [OPG study]4.3990628
GSM549140patient 044, cancer, homogenized [OPG study]7.2434173
GSM549111patient 047, normal, homogenized [OPG study]8.5000785
GSM549113patient 057, normal, homogenized [OPG study]5.5157751
GSM549132patient 031, cancer, homogenized [OPG study]5.5994152
GSM549137patient 038, cancer, homogenized [OPG study]5.8990857
GSM549142patient 047, cancer, homogenized [OPG study]4.6605330
GSM549100patient 110, normal, homogenized [OPG study]4.4263727
GSM549107patient 135, normal, homogenized [OPG study]5.1925745
GSM549115patient 068, normal, homogenized [OPG study]4.7837537
GSM549116patient 072, normal, homogenized [OPG study]4.1415320
GSM549120patient 078, normal, homogenized [OPG study]6.1521260
GSM549131patient 030, cancer, homogenized [OPG study]4.5782132
GSM549118patient 074, normal, homogenized [OPG study]4.5299530
GSM549129patient 027, cancer, homogenized [OPG study]4.0258216
GSM549123patient 088, normal, homogenized [OPG study]3.9434614
GSM549124patient 006, cancer, homogenized [OPG study]4.3642725
GSM549126patient 015, cancer, homogenized [OPG study]7.4884777
GSM549128patient 025, cancer, homogenized [OPG study]4.9615940
GSM549103patient 117, normal, homogenized [OPG study]4.1202418
GSM549117patient 073, normal, homogenized [OPG study]4.2799124
GSM549138patient 041, cancer, homogenized [OPG study]4.1253420
GSM549141patient 045, cancer, homogenized [OPG study]4.3288326
GSM549130patient 028, cancer, homogenized [OPG study]4.568730
GSM549101patient 111, normal, homogenized [OPG study]4.3772226
GSM549105patient 128, normal, homogenized [OPG study]4.1917221
GSM549106patient 134, normal, homogenized [OPG study]5.8685357
GSM549112patient 048, normal, homogenized [OPG study]4.1795621
GSM549125patient 011, cancer, homogenized [OPG study]4.5894731
GSM549127patient 024, cancer, homogenized [OPG study]6.6073266
GSM549135patient 035, cancer, homogenized [OPG study]4.1787422